On the other hand, not every crowd-sourced innovation will turn out to be safe or effective
Tony Blair Institute for Global Change
Who Should Avoid Peptide Therapy
What Goes Away vs What You Manage Long-Term Goes Away for Most Patients Nausea (resolves 8090% by month 3) Vomiting (resolves 95%+ by month 2) Fatigue (resolves as body adapts to deficit) Diarrhea (transient, resolves quickly) Injection site reactions (skin adapts) May Need Ongoing (Low-Effort) Management Constipation (magnesium + fiber + water 2 min/day) Mild bloating after large meals (eat smaller, more often) Acid reflux (3-hr food gap + elevated bed once set up, zero effort) Hair thinning (protein + time temporary, self-resolving) Reduced alcohol tolerance (drink less, slower) Left column disappears
Intravenous Skin-Lightening Claims Evidence for intravenous glutathione used specifically for skin lightening is substantially weaker and carries additional injection and product-quality risks
Indeed, these studies are burdened by several limitations, most importantly the small sample size and the lack of evaluation of the therapeutic effect of GSH by liver biopsy, which to date is the gold standard for the definition of steatosis and fibrosis levels